NCT02289859

Brief Summary

The purpose of this study is to determine whether undermining during cutaneous surgery improves scar cosmesis compared to wound closure without undermining.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 13, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

July 18, 2017

Status Verified

July 1, 2017

Enrollment Period

1.9 years

First QC Date

November 10, 2014

Last Update Submit

July 17, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of Scar on the Patient and Observer Scar Assessment Scale

    After surgical procedure, half of the subject's wound will be closed after undermining, while the other half is closed without undermining. After 3 months, subjects will return to clinic for evaluation of the cosmesis of both types of closure techniques.

    3 months

Secondary Outcomes (2)

  • Measurement of Scar Width

    3 months

  • Assessment of Complications

    3 months

Study Arms (2)

Wound Closure with Undermining

ACTIVE COMPARATOR

The side assigned to undermining will have undermining performed prior to wound closure in the subcutaneous plane. The amount of undermining will range from 1 cm for wounds with low tension to 2 cm for those with moderate tension. Since wound diameter will be 3 cm or less and exclude the scalp, high tension wounds are not anticipated.

Procedure: Wound Closure with UnderminingProcedure: Wound Closure without Undermining

Wound Closure without Undermining

ACTIVE COMPARATOR

One side of the wound will remain un-undermined.

Procedure: Wound Closure with UnderminingProcedure: Wound Closure without Undermining

Interventions

The side assigned to undermining will have undermining performed prior to wound closure in the subcutaneous plane. The amount of undermining will range from 1 cm for wounds with low tension to 2 cm for those with moderate tension. Since wound diameter will be 3 cm or less and exclude the scalp, high tension wounds are not anticipated.

Wound Closure with UnderminingWound Closure without Undermining

One side of the wound will remain un-undermined.

Wound Closure with UnderminingWound Closure without Undermining

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to give informed consent themselves
  • Patient scheduled for cutaneous surgical procedure with predicted linear closure
  • Willing to return for follow up visits

You may not qualify if:

  • Mentally handicapped
  • Incarceration
  • Pregnant Women
  • Wounds with predicted closure length less than 3 cm
  • Wounds with diameter \> 3 cm
  • Wounds unable to be fully closed without undermining

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Joo J, Pourang A, Tchanque-Fossuo CN, Armstrong AW, Tartar DM, King TH, Sivamani RK, Eisen DB. Undermining during cutaneous wound closure for wounds less than 3 cm in diameter: a randomized split wound comparative effectiveness trial. Arch Dermatol Res. 2022 Sep;314(7):697-703. doi: 10.1007/s00403-021-02280-5. Epub 2021 Sep 21.

Related Links

Study Officials

  • Daniel Eisen, M.D.

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2014

First Posted

November 13, 2014

Study Start

May 1, 2014

Primary Completion

April 1, 2016

Study Completion

July 1, 2016

Last Updated

July 18, 2017

Record last verified: 2017-07